Trypanosomiasis clinical trials
The registry lists 8 studies for Trypanosomiasis across more than 10 countries. 1 are recruiting or about to start. 1 of them are mainly about Trypanosomiasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-27. Counting its 3 narrower conditions too, such as Chagas Disease: 107 studies, 8 open.
Get an email when these change. Save the Trypanosomiasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Institut de Recherche pour le Developpement (3) · Drugs for Neglected Diseases (2) · Population Health Research Institute (1) · Epicentre (1) · Institute of Tropical Medicine, Belgium (1)
What is being tested here
Drugs under test in Trypanosomiasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| SCYX 7158 | 1 | 1 | 2 |
| Fexinidazole | 0 | 1 | 1 |
| Benzonidazole | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Dec 2026Stop Transmission of Gambiense Human African Trypanosomiasis · Phase 3 · Institute of Tropical Medicine, Belgium
Who these studies take
Of the 1 Trypanosomiasis studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 8 studies, recruiting or not: 25% stop at 75 or younger and 13% at 65; 75% take children; 0% are for women only and 13% for men only; 38% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. search them.
- Stop Transmission of Gambiense Human African TrypanosomiasisRecruitingNCT07789743Phase 31 country
- Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any StageCompletedNCT03025789Phase 32 countries
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination MonitoringCompletedNCT04099628Not applicable3 countries
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case DetectionCompletedNCT03356665Not applicable3 countries
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cureCompletedNCT03112655Not applicable1 country
- BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' DiseaseCompletedNCT00123916Phase 35 countries
- Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158CompletedNCT01533961Phase 11 country
- Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African TrypanosomiasisTerminatedNCT00330148Phase 31 country